Jordan Schaefer

[JAMA Network Open @JAMANetworkOpen]

#EHR does a reasonably good job at identifying aspirin use in patients without a history of cardiovascular disease. Efforts to improve medication reconciliation, including OTC meds, would improve accuracy and reliability. https://t.co/HOChxecWWt

[Anticoagulation Forum @AnticoagForum]

Webinar Recording Now Available!

Aspirin De-Prescribing and PPI Prescribing: Gastroprotection Among Patients Taking Oral Anticoagulants

Presenters: Jacob Kurlander, MD, MS & Jordan Schaefer, MD, FACP

Watch Now: https://t.co/AoQd90Tg0B

[Anand Padmanabhan @AnandPheresisMD]

Recurrent thrombosis and MGUS? Great story on how we diagnosed our patient with a new #thrombophilia #MGTS Monoclonal gammopathy of thrombotic significance with colleague @JordanKSchaefer @mayocliniclabs @MayoClinicPath @MayoClinic https://t.co/iedN5tTK9P

[Anand Padmanabhan @AnandPheresisMD]

Excited about our @BloodJournal paper on a new thrombophilia: #MGTS characterized by thrombosis due to MONOCLONAL anti-PF4 antibodies. Congrats to colleagues from multiple institutions for this breakthrough finding!! @mayocliniclabs @MayoClinic @umichCVC https://t.co/j8d55E5pD1

[JAMA Network Open @JAMANetworkOpen]

An anticoagulation clinic–based #aspirin deimplementation intervention was associated with improved guideline-concordant aspirin use and fewer bleeding complications. https://t.co/kxKFZOdhae #Research

[ASH @ASH_hematology]

Today, we proudly announce the 36 recipients of our 2022 ASH Scholar Awards, one of our most prestigious research award programs for fellows & junior faculty dedicating a #career to #hematology research! 🎉🩸 #ASHAwards

Read about our awardees today: https://t.co/yFKADiKxpB

[Michael Makris @ProfMakris]

Jordan Schaefer compared DOAC+aspirin vs Warfarin+aspirin for AF or VTE. Not RCT. No differences in thrombosis or bleeding, except perhaps a higher bleeding risk for Rivaroxaban. #ASH21

[Ming Y Lim 明林 @heme_fan]

Proud to co-author this paper with Dr Jordan Schaefer at @UMich for @JNCCN. Hope it is helpful in determining which AC to use.

@huntsmancancer @UtahHemeOnc

How to Choose An Appropriate Anticoagulant for Cancer-Associated Thrombosis

https://t.co/FK5Jy72nDF

[Tania Ahuja 👩🏻‍💻🫀 @TaniaAhuja]

✅ out our 📝 & response to our 🙋🏻‍♀️🙋🏽‍♂️ to⤵️
https://t.co/kbyVKsMBug
🙏🏼 @JordanKSchaefer @GBarnesMD
💌To Deprescribe or Not to Deprescribe Aspirin💌
team #droptheASA ❣️
https://t.co/l4HQEL4YtX via @JAMAInternalMed part of @JAMANetwork
@amanmadh @PlateletDoc https://t.co/neYVdYXsRJ

[ASH Clinical News @ASHClinicalNews]

When 1+1=-1: People taking both DOACs and low-dose aspirin had significantly higher bleeding rates than those taking a DOAC alone: 31.6 bleeds vs. 26.0 bleeds per 100 patient-years.

[2 Minute Medicine® @2minmed]

#VisualAbstract: Aspirin treatment without indication in patients on direct oral anticoagulants may increase the risk of bleeding events https://t.co/A1Ys4yRjiT #StudyGraphics #aspirin

[U-M Medical School Research @UMichMedScience]

Just out in @JAMAInternalMed: Adding aspirin to a direct oral anticoagulant is an equation that rarely adds up for some patients.
https://t.co/zXFDAETmQP

[Geoff Barnes @GBarnesMD]

Combined #DOAC plus #aspirin when there isn't a strong indication is associated with higher rates of non-major bleeding. Similar findings with warfarin use. Important findings from @MAQI_2 in @JAMAInternalMed https://t.co/9Xji1LnwG8

[JTH @JTHjournal]

New article: Venous #thrombosis is leading cause of death in #cancer Low molecular weight heparin & direct oral anticoagulants used to treat cancer associated thrombosis. Schaefer, @MarcCarrier1 et al @UMich find pts remain on DOACs longer.
https://t.co/2tIW3WU0pt

[MAQI2 @MAQI_2]

Come visit our booth (#2309) at the 61st ASH Annual Meeting @ASH_hematology to learn about our free anticoagulation resources. #ASH19 #MAQI2 #anticoagulation

[U-M Health Frankel CVC @umichCVC]

NEW in @JAMAInternalMed, @GBarnesMD and team found more than 1/3 of patients risked major bleeding by doubling up on blood thinners:
https://t.co/OXkVsQdbTC